Analysis | Metabolite Name | Measured Value | Units | Urease Treatment | Volume Urine (µL) | Gender | Solution Added | Ethnicity |
---|---|---|---|---|---|---|---|---|
MS positive ion mode | L-pyroglutamic acid | 513971 | Peak area | Urease pre-treatment | 50 | Female | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 969532 | Peak area | Urease pre-treatment | 50 | Female | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 2151975.161 | Peak area | Urease pre-treatment | 5 | N/A | N/A | N/A |
MS positive ion mode | L-pyroglutamic acid | 2348860.859 | Peak area | Urease pre-treatment | 5 | N/A | N/A | N/A |
MS positive ion mode | L-pyroglutamic acid | 2399117.709 | Peak area | No treatment | 5 | N/A | N/A | N/A |
MS positive ion mode | L-pyroglutamic acid | 2417846.978 | Peak area | Urease pre-treatment | 5 | N/A | N/A | N/A |
MS positive ion mode | L-pyroglutamic acid | 2485936.797 | Peak area | No treatment | 5 | N/A | N/A | N/A |
MS positive ion mode | L-pyroglutamic acid | 2727777.908 | Peak area | No treatment | 5 | N/A | N/A | N/A |
MS positive ion mode | L-pyroglutamic acid | 3304849.143 | Peak area | No treatment | 50 | Male | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 3503193.171 | Peak area | Urease pre-treatment | 50 | Male | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 3591106.943 | Peak area | No treatment | 50 | Male | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 3972967.6 | Peak area | Urease pre-treatment | 50 | Male | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 4077591.461 | Peak area | Urease pre-treatment | 10 | N/A | N/A | N/A |
MS positive ion mode | L-pyroglutamic acid | 4094777.114 | Peak area | Urease pre-treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 4179049.299 | Peak area | Urease pre-treatment | 10 | N/A | N/A | N/A |
MS positive ion mode | L-pyroglutamic acid | 4261835.001 | Peak area | Urease pre-treatment | 10 | N/A | N/A | N/A |
MS positive ion mode | L-pyroglutamic acid | 4264477.775 | Peak area | No treatment | 10 | N/A | N/A | N/A |
MS positive ion mode | L-pyroglutamic acid | 4547143.714 | Peak area | No treatment | 50 | Female | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 4739963.052 | Peak area | No treatment | 10 | N/A | N/A | N/A |
MS positive ion mode | L-pyroglutamic acid | 4923281.92 | Peak area | No treatment | 10 | N/A | N/A | N/A |
MS positive ion mode | L-pyroglutamic acid | 5302830.343 | Peak area | Urease pre-treatment | 50 | Female | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 5303419.171 | Peak area | No treatment | 50 | Female | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 5620499.771 | Peak area | Urease pre-treatment | 50 | Female | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 6318766.943 | Peak area | Urease pre-treatment | 50 | Female | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 6631205.486 | Peak area | No treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 6720209.886 | Peak area | Urease pre-treatment | 50 | Female | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 8622728.143 | Peak area | No treatment | 50 | Female | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 8688004.571 | Peak area | Urease pre-treatment | 50 | Female | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 8790901.571 | Peak area | No treatment | 50 | Female | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 8824009.086 | Peak area | Urease pre-treatment | 50 | Female | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 9152302.914 | Peak area | Urease pre-treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 9260952 | Peak area | No treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 9369044.238 | Peak area | Urease pre-treatment | 25 | N/A | N/A | N/A |
MS positive ion mode | L-pyroglutamic acid | 10425447.95 | Peak area | Urease pre-treatment | 25 | N/A | N/A | N/A |
MS positive ion mode | L-pyroglutamic acid | 10494780.18 | Peak area | Urease pre-treatment | 25 | N/A | N/A | N/A |
MS positive ion mode | L-pyroglutamic acid | 10904148.55 | Peak area | No treatment | 25 | N/A | N/A | N/A |
MS positive ion mode | L-pyroglutamic acid | 11050927.85 | Peak area | No treatment | 25 | N/A | N/A | N/A |
MS positive ion mode | L-pyroglutamic acid | 11907786.73 | Peak area | No treatment | 25 | N/A | N/A | N/A |
MS positive ion mode | L-pyroglutamic acid | 12116116.74 | Peak area | No treatment | 50 | Female | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 12828585.83 | Peak area | No treatment | 50 | Male | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 13456163.83 | Peak area | No treatment | 50 | Female | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 14508251.71 | Peak area | Urease pre-treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 14541434.6 | Peak area | Urease pre-treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 16034951.86 | Peak area | Urease pre-treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 17445749.4 | Peak area | Urease pre-treatment | 50 | Male | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 18233162.94 | Peak area | Urease pre-treatment | 50 | Male | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 18596919.01 | Peak area | Urease pre-treatment | 50 | N/A | N/A | N/A |
MS positive ion mode | L-pyroglutamic acid | 19083708.63 | Peak area | No treatment | 50 | Male | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 19124594.23 | Peak area | Urease pre-treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 19311932.45 | Peak area | Urease pre-treatment | 50 | N/A | N/A | N/A |
MS positive ion mode | L-pyroglutamic acid | 19379585.94 | Peak area | Urease pre-treatment | 50 | Male | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 19484035.71 | Peak area | No treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 19518991.5 | Peak area | Urease pre-treatment | 50 | N/A | N/A | N/A |
MS positive ion mode | L-pyroglutamic acid | 19519679.77 | Peak area | No treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 19661077.86 | Peak area | Urease pre-treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 19990052.97 | Peak area | No treatment | 50 | Male | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 20210666.74 | Peak area | Urease pre-treatment | 50 | Female | N/A | Asian |
MS positive ion mode | L-pyroglutamic acid | 20368595.34 | Peak area | Urease pre-treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 20809496.29 | Peak area | Urease pre-treatment | 50 | Female | N/A | Asian |
MS positive ion mode | L-pyroglutamic acid | 20815075.97 | Peak area | Urease pre-treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 21515553.14 | Peak area | No treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 21631164.66 | Peak area | Urease pre-treatment | 50 | Male | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 21816280.14 | Peak area | Urease pre-treatment | 50 | Male | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 22393180.09 | Peak area | No treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 23312140.17 | Peak area | Urease pre-treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 23742146.03 | Peak area | No treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 23777939.83 | Peak area | No treatment | 50 | Male | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 24064807.83 | Peak area | Urease pre-treatment | 50 | Male | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 24188468.97 | Peak area | No treatment | 50 | Female | N/A | Black |
MS positive ion mode | L-pyroglutamic acid | 24383975.71 | Peak area | Urease pre-treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 25096124.23 | Peak area | Urease pre-treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 25137465.6 | Peak area | No treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 25465192.06 | Peak area | Urease pre-treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 25533857.89 | Peak area | No treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 25783744.77 | Peak area | No treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 25956063.09 | Peak area | No treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 25958095.71 | Peak area | Urease pre-treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 26013923.03 | Peak area | Urease pre-treatment | 50 | Male | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 26209279.2 | Peak area | No treatment | 50 | Male | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 26309069.49 | Peak area | No treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 26418927.48 | Peak area | No treatment | 50 | N/A | N/A | N/A |
MS positive ion mode | L-pyroglutamic acid | 26730453.8 | Peak area | No treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 26785261.63 | Peak area | No treatment | 50 | Male | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 26856479.91 | Peak area | Urease pre-treatment | 50 | Female | N/A | Black |
MS positive ion mode | L-pyroglutamic acid | 27348509.79 | Peak area | No treatment | 50 | N/A | N/A | N/A |
MS positive ion mode | L-pyroglutamic acid | 27493078.09 | Peak area | Urease pre-treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 27510329.71 | Peak area | Urease pre-treatment | 50 | Female | N/A | Black |
MS positive ion mode | L-pyroglutamic acid | 27909156.34 | Peak area | No treatment | 50 | Male | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 28007585.83 | Peak area | Urease pre-treatment | 50 | Female | N/A | Asian |
MS positive ion mode | L-pyroglutamic acid | 28074196.37 | Peak area | No treatment | 50 | N/A | N/A | N/A |
MS positive ion mode | L-pyroglutamic acid | 28090262.51 | Peak area | Urease pre-treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 28705901.26 | Peak area | No treatment | 50 | Female | N/A | Black |
MS positive ion mode | L-pyroglutamic acid | 28781091.94 | Peak area | No treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 28901283.09 | Peak area | Urease pre-treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 28990480.51 | Peak area | Urease pre-treatment | 50 | Female | N/A | Asian |
MS positive ion mode | L-pyroglutamic acid | 29403804.66 | Peak area | Urease pre-treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 29412874.97 | Peak area | No treatment | 50 | Male | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 29637720.6 | Peak area | Urease pre-treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 29794058.63 | Peak area | Urease pre-treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 29875634.06 | Peak area | No treatment | 50 | Female | N/A | Asian |
MS positive ion mode | L-pyroglutamic acid | 30585728 | Peak area | No treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 30797309.23 | Peak area | Urease pre-treatment | 50 | Male | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 31043825.26 | Peak area | No treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 31084543.77 | Peak area | No treatment | 50 | Male | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 31156797.86 | Peak area | Urease pre-treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 31360775.69 | Peak area | No treatment | 50 | Male | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 31725184.23 | Peak area | No treatment | 50 | Male | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 32222879.06 | Peak area | No treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 32365669.74 | Peak area | No treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 32395332.09 | Peak area | Urease pre-treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 32789202.29 | Peak area | No treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 32916365.09 | Peak area | Urease pre-treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 33139576.06 | Peak area | Urease pre-treatment | 50 | Male | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 33179302.86 | Peak area | No treatment | 50 | Female | N/A | Asian |
MS positive ion mode | L-pyroglutamic acid | 33224966.43 | Peak area | No treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 33496088.91 | Peak area | No treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 33700072.46 | Peak area | No treatment | 50 | Male | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 33941566.86 | Peak area | Urease pre-treatment | 50 | Male | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 34009841.46 | Peak area | Urease pre-treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 34449479 | Peak area | Urease pre-treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 34488601.77 | Peak area | No treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 34582073.23 | Peak area | No treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 34939536.91 | Peak area | Urease pre-treatment | 50 | Male | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 35120582.09 | Peak area | No treatment | 50 | Male | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 35714834.63 | Peak area | Urease pre-treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 36080898.69 | Peak area | No treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 36455570.74 | Peak area | No treatment | 50 | Female | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 36831565.23 | Peak area | No treatment | 50 | Female | N/A | Asian |
MS positive ion mode | L-pyroglutamic acid | 37360308.29 | Peak area | No treatment | 50 | Female | N/A | Black |
MS positive ion mode | L-pyroglutamic acid | 37382164.26 | Peak area | Urease pre-treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 37427725.49 | Peak area | No treatment | 50 | Female | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 37508826.46 | Peak area | No treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 37640544.69 | Peak area | No treatment | 50 | Female | N/A | Black |
MS positive ion mode | L-pyroglutamic acid | 37804049.43 | Peak area | No treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 38121271.54 | Peak area | Urease pre-treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 38190332.49 | Peak area | Urease pre-treatment | 50 | Male | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 38799394.53 | Peak area | Urease pre-treatment | 100 | N/A | N/A | N/A |
MS positive ion mode | L-pyroglutamic acid | 38914146.51 | Peak area | No treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 38924849.03 | Peak area | No treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 38949643.2 | Peak area | Urease pre-treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 39168343.97 | Peak area | Urease pre-treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 39398322.52 | Peak area | Urease pre-treatment | 100 | N/A | N/A | N/A |
MS positive ion mode | L-pyroglutamic acid | 39799343.54 | Peak area | No treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 40301011.2 | Peak area | Urease pre-treatment | 50 | Female | N/A | Black |
MS positive ion mode | L-pyroglutamic acid | 40773323.04 | Peak area | No treatment | 100 | N/A | N/A | N/A |
MS positive ion mode | L-pyroglutamic acid | 41817212.34 | Peak area | No treatment | 50 | Female | N/A | Asian |
MS positive ion mode | L-pyroglutamic acid | 42089948.06 | Peak area | Urease pre-treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 42300528.98 | Peak area | Urease pre-treatment | 100 | N/A | N/A | N/A |
MS positive ion mode | L-pyroglutamic acid | 42395342.74 | Peak area | Urease pre-treatment | 50 | Female | N/A | Black |
MS positive ion mode | L-pyroglutamic acid | 42871817.66 | Peak area | Urease pre-treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 42891292 | Peak area | Urease pre-treatment | 50 | Male | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 42970962.51 | Peak area | Urease pre-treatment | 50 | Male | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 43973164.4 | Peak area | No treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 44953090.91 | Peak area | No treatment | 50 | Male | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 45550923.94 | Peak area | Urease pre-treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 45739951.66 | Peak area | Urease pre-treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 46128234.17 | Peak area | Urease pre-treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 46283575.71 | Peak area | No treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 46400782.09 | Peak area | Urease pre-treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 46434629.31 | Peak area | Urease pre-treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 46709832.11 | Peak area | Urease pre-treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 47355159.09 | Peak area | No treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 47865798.64 | Peak area | No treatment | 100 | N/A | N/A | N/A |
MS positive ion mode | L-pyroglutamic acid | 48078940.18 | Peak area | No treatment | 100 | N/A | N/A | N/A |
MS positive ion mode | L-pyroglutamic acid | 48973108.11 | Peak area | Urease pre-treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 49981743.54 | Peak area | No treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 50477270.4 | Peak area | Urease pre-treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 51252585.83 | Peak area | No treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 51449701.94 | Peak area | No treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 51551737.49 | Peak area | Urease pre-treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 52842337.54 | Peak area | Urease pre-treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 54428228.34 | Peak area | No treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 56905794.74 | Peak area | No treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 56995288.23 | Peak area | Urease pre-treatment | 50 | Male | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 57088073.49 | Peak area | Urease pre-treatment | 50 | Male | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 57772779.66 | Peak area | No treatment | 50 | Male | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 59381343.09 | Peak area | No treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 60490959.09 | Peak area | No treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 60653283.2 | Peak area | No treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 61354402.06 | Peak area | No treatment | 50 | Male | N/A | Hispanic |
MS positive ion mode | L-pyroglutamic acid | 61356907.54 | Peak area | Urease pre-treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 61834695.54 | Peak area | Urease pre-treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 63615068.8 | Peak area | No treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 65868828.11 | Peak area | No treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 71070724.34 | Peak area | No treatment | 50 | Male | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 73595624.23 | Peak area | No treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 76083468.8 | Peak area | No treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 79332689.6 | Peak area | Urease pre-treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 84167806.4 | Peak area | Urease pre-treatment | 50 | Female | N/A | Caucasian |
MS positive ion mode | L-pyroglutamic acid | 86039877.71 | Peak area | No treatment | 50 | Female | N/A | Caucasian |